Clinical trial
Effect of Rosiglitazone on ADMA in Critical Illness
NCT00409097 · Amsterdam UMC, location VUmc, Other · Unknown status
Key facts
| NCT number | NCT00409097 |
|---|---|
| Title | Effect of Rosiglitazone on ADMA in Critical Illness |
| Lead sponsor | Amsterdam UMC, location VUmc, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Critical Illness, Multiple Organ Failure |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Dec 8, 2006 |
| Last update posted | Dec 8, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: